Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 24;19(3):3793-803.
doi: 10.3390/molecules19033793.

Antischistosomal activity of the terpene nerolidol

Affiliations

Antischistosomal activity of the terpene nerolidol

Marcos P N Silva et al. Molecules. .

Abstract

Schistosomiasis is a neglected tropical disease that affects hundreds of millions of people worldwide. Since the treatment of this disease currently relies on a single drug, praziquantel, new and safe schistosomicidal agents are urgently required. Nerolidol, a sesquiterpene present in the essential oils of several plants, is found in many foods and was approved by the U.S. Food and Drug Administration. In this study we analysed the in vitro antiparasitic effect of nerolidol on Schistosoma mansoni adult worms. Nerolidol at concentrations of 31.2 and 62.5 μM reduced the worm motor activity and caused the death of all male and female schistosomes, respectively. In addition, confocal laser scanning microscopy revealed morphological alterations on the tegument of worms such as disintegration, sloughing and erosion of the surface, and a correlation between viability and tegumental damage was observed. In conclusion, nerolidol may be a promising lead compound for the development of antischistosomal natural agents.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structure of nerolidol: cis-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol and trans-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol.
Figure 2
Figure 2
In vitro effect of nerolidol on the survival of Schistosoma mansoni after 24 h (A), 48 h (B) and 120 h (C) of treatment. Pairs of adult worms, males (closed bars) and females (open bars), were incubated in 24-well culture plates containing RPMI 1640 medium and treated with nerolidol at different concentrations. Mortality data are presented from ten worm couples and values correspond to the sum of the adult schistosomes obtained from three separate experiments performed in triplicate (n = 2) and quadruplicate (n = 1).
Figure 3
Figure 3
Microscopy investigation of Schistosoma mansoni male worm after in vitro incubation with nerolidol. After 5 days or in the case of death, schistosomes were fixed and monitored using a confocal microscopy. (A) Negative control. (B) 62.5 µM nerolidol. (C) 125 µM nerolidol. (D) 250 µM nerolidol. Scale bars = 50 µm.
Figure 4
Figure 4
Morphological changes on the tegument of S. mansoni male worms after treatment with nerolidol. Quantitative analysis, measured in a 20,000 µm2 of area in a dorsal region of male parasite, was performed using three-dimensional images obtained from confocal microscope (see Figure 3). A minimum of three tegument areas of each parasite were assessed. Values are means ± SD (bars) of ten male adult worms. *** p < 0.001 compared with untreated groups.

References

    1. Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J. Schistosomiasis and water resources development: Systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. 2006;6:411–425. doi: 10.1016/S1473-3099(06)70521-7. - DOI - PubMed
    1. Van der Werf M.J., de Vlas S.J., Brooker S., Looman C.W., Nagelkerke N.J., Habbema J.D., Engels D. Quantification of clinical morbidity associated with schistosome infection in sub Saharan Africa. Acta Trop. 2003;86:125–139. doi: 10.1016/S0001-706X(03)00029-9. - DOI - PubMed
    1. Gray D.J., McManus D.P., Li Y., Williams G.M., Bergquist R. Schistosomiasis elimination: Lessons from the past guide the future. Lancet Infect. Dis. 2010;10:733–736. doi: 10.1016/S1473-3099(10)70099-2. - DOI - PubMed
    1. Gryseels B., Polman K., Clerinx J., Kestens L. Human schistosomiasis. Lancet. 2006;368:1106–1118. doi: 10.1016/S0140-6736(06)69440-3. - DOI - PubMed
    1. Fallon P.G., Doenhoff M.J. Drug-resistant schistosomiasis: Resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop Med. Hyg. 1994;51:83–88. - PubMed

Publication types

LinkOut - more resources